Medical Disorders
Resources
Basic InformationLookupsLatest News
Do Immune-Based Cancer Drugs Work Better in Men?Gene Found in Amish Helps Protect Their HeartsOmicron May Overcome Prior COVID InfectionWindy Days Are Safer Days When It Comes to COVID-19Most Vaccinated Adults Plan to Get Boosters: PollStudy Finds Delta Somewhat Resistant to Vaccines — What About Omicron?Is the Mumps Vaccine Becoming Less Effective?Vaping Can Trigger Gene Changes in Cells: StudyPfizer or Moderna? Head-to-Head Study Shows One Shot Has an EdgeSurvivors of Severe COVID Face Doubled Risk for Death a Year LaterKids With Uncontrolled Asthma at Higher Odds for Severe COVID-19Nearly 7% of U.S. Kids Have Had a Head Injury or ConcussionFirst U.S. Omicron Case Reported in CaliforniaCDC to Toughen COVID Testing for International TravelersCertain Blood Thinners Can Raise Risk of 'Delayed' Bleeding After Head InjuryFDA Panel Gives Support to Merck's COVID Antiviral PillLong-Haul COVID Can Include Chronic Fatigue: StudyVaccines, Boosters Should Protect Against Severe COVID, Even With Omicron: FauciPfizer to Seek FDA Approval of Boosters for Teens Ages 16-17Regeneron Says Its Antibody Cocktail Likely Weakened by Omicron VariantCOVID May Trigger Heart Condition in Young AthletesMany People With High Blood Pressure May Take a Drug That Worsens It: StudyBiden Pushes Vaccines, Masks as Best Defense Against Omicron VariantHow Easily Can Singing Spread COVID-19?New Insights Into What Might Drive Parkinson's DiseaseHot Days Can Send Even Younger Folks to the ERRed Light in Morning May Protect Fading Eyesight: StudyMerck's COVID Pill Appears Effective, But May Pose Pregnancy Risks: FDAVaccine Makers Already Testing Their Shots Against Omicron VariantWhat Experts Know About the Omicron 'Variant of Concern'What You Need to Know About Stomach CancerFetal Infection With COVID-19 Possible, But UnlikelyCOVID Protection Wanes After 2 Doses of Pfizer Vaccine: StudyRural Hospitals' ERs Just as Effective as Urban Ones: StudyBoosters: What You Need to KnowAHA News: Pulmonary Embolism Is Common and Can Be Deadly, But Few Know the SignsAlmost 1 in Every 3 College-Age Americans Are Now ObeseAnimal Study Offers Hope for a Vaccine Against Lyme DiseaseAddictive Opioid Painkillers Might Not Be Needed After Knee SurgeryYears of Blood Thinners After Stenting Might Not Be NecessaryU.S. COVID Cases, Hospitalizations on the Rise Just Before ThanksgivingVaping Could Weaken Your Bones, Study FindsWearable Vibration Device May Ease Parkinson's TremorPfizer Says Its COVID Vaccine Provides Full Protection to AdolescentsBooster Shots Prompt Stronger, Longer Protection Than Original Shots: StudyTV Remotes, Nurse Call Buttons: Where Coronavirus Lingers in Nursing HomesBlood Pressure During Surgery May Be Crucial After Spinal Cord InjuryPeople on Immune-Suppressing Meds Fare Equally Well With Severe COVIDDelta Variant Ups Risk of Stillbirth, Death During Pregnancy, Reports ShowAre You at Risk for Stress Urinary Incontinence?
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Moderna Asks FDA to OK Its Booster Shot for All Adults

HealthDay News
by Robert Preidt and Robin Foster
Updated: Nov 18th 2021

new article illustration

THURSDAY, Nov. 18, 2021 (HealthDay News) -- Moderna asked the U.S. Food and Drug Administration on Wednesday to allow emergency use of the company's coronavirus vaccine booster for all adults aged 18 and older.

Currently, the booster is approved for people 65 and older, along with adults in long-term care homes, those with underlying medical conditions and those with jobs that put them at high risk of exposure, the company said in a news release. The booster is given six months after the second shot of the two-dose initial vaccination series.

Moderna's booster is half the dose of the initial vaccination series: 50 micrograms vs. 100 micrograms.

New York City and some states aren't waiting for federal approval and have already made Moderna booster shots available to all adults.

The Moderna vaccine has been shown to be safe overall, but is associated with a small but increased risk of heart inflammation (myocarditis), particularly in young men.

"These cases are typically mild," Moderna Chief Medical Officer Dr. Paul Burton said at a news briefing earlier this month, NBC News reported. "While we don't fully understand the reasons and the etiology behind this, we think that it may be driven by testosterone."

He noted that no cases of myocarditis in young men have been reported in clinical trials of the booster doses, and added that the benefits of vaccination far outweigh any risks.

The FDA is expected to soon give the green light to Pfizer's COVID-19 vaccine booster shot for all adults, and it will be discussed at a U.S. Centers for Disease Control and Prevention advisory panel meeting scheduled for Friday.

Some experts still question the need for a booster among younger adults.

"By and large, healthy, younger people who have been vaccinated are handling breakthrough infections well," Dr. Jesse Goodman, a former chief scientist with the FDA and a professor of medicine and infectious diseases at Georgetown Medical Center in Washington, D.C.

"People have to realize giving a third dose of vaccine to healthy young people is not going to affect the pandemic," he told NBC News. "The way we're going to do that is by getting unvaccinated people immunized."

More information

Visit the U.S. Food and Drug Administration for more on COVID vaccines.


SOURCE: NBC News




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net